Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Elite Skills Arena (ESA) provide a range of training aids to improve performance. All ESA products are based around repetition, maximising training intensity for a more pronounced improvement.
days to go:
Expired
investment:
£72,603
Enertor is a sole manufacturer which uses smart material that cushions the foot when moved slowly, but on impact locks together to absorb and disperse energy, before instantly returning to its flexible state which reduces the risk of injury. The global orthotics market is worth $ 6.5 Billion per annum, of which approximately $ 3.5 Billion is foot orthotics and growing at 7% CAGR per annum. The company is on a mission to help everyone stay injury-free with their shock-absorbing insoles. They have strong endorsements from elite athletes, including Usain Bolt & the British Military. Their shock-absorbing insoles are to be mandated by the British Armed Forces, including the Royal Marines and SAS. With the proceeds, the company will develop its website, further research and development, IP protection and patent filing, marketing and working capital for the business.
days to go:
Expired
investment:
£509,999
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.
days to go:
Expired
investment:
£891,790
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment. The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go:
Expired
investment:
£300,290
A clothing brand that makes stylish, casual-wear garments in Great Britain targeted at men aged over 35. Blackshore consists of an experienced team that have created their first clothing collection, which is now ready for production after passing a sample test. The theme of this first range is for men who enjoy relaxing at coastal locations. One of the company's unique selling point is that repairs to garments are guaranteed for life. A website has already been built to showcase the brand's products, as well as being a sales channel.
days to go:
Expired
investment:
£13,910
Mogees is a London-based company with the objective to disrupt the relationship between people and physical objects. Their patent-pending technology allows anyone to transform ordinary physical objects into ‘smart’ ones through the power of machine learning and a vibration sensor.
days to go:
Expired
investment:
£1,153,867
